LINDA TODD: Open Payments
NPI 1295313302 · MC LEAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,759 in 71 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $995 · 2025 $2,759
Food & beverage: $2,708Consulting: $51
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $521 |
| CSL Behring | 8 | $311 |
| PFIZER INC. | 4 | $293 |
| GENZYME CORPORATION | 9 | $278 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $213 |
| GlaxoSmithKline, LLC. | 6 | $206 |
| Pharming Healthcare, Inc. | 7 | $160 |
| Novo Nordisk Inc | 1 | $125 |
| Grifols USA, LLC | 3 | $84 |
Products named: TEZSPIRE, DUPIXENT, CIBINQO, NEFFY, Andembry, CUVITRU, RUCONEST, NUCALA.
Industry payments across VA — which companies pay providers there.
